Literature DB >> 1588973

Role of the liver-enriched transcription factor DBP in expression of the cytochrome P450 CYP2C6 gene.

M Yano1, E Falvey, F J Gonzalez.   

Abstract

The CYP2C6 gene becomes maximally transcriptionally activated in livers of postpubertal rats. We examined the role of upstream DNA and liver-specific transcription factors in regulation of this promoter by use of transient transfection of heterologous chloramphenicol acetyltransferase gene constructs and vectors containing cDNAs encoding the liver-enriched transcription factors HNF-1 alpha, C/EBP, and DBP. Only DBP was able to activate the CYP2C6 promoter in HepG2 cells. Transactivation was not observed in one mouse and two human nonhepatic origin cell lines tested. Analysis of various constructs in which CYP2C6 upstream DNA was deleted revealed that DNA between -38 to -103 was involved in DBP-mediated activation. A partially purified preparation of DBP produced a footprint between -43 and -64 bp upstream of the transcription start site. A 32P-labeled double-stranded oligonucleotide, containing sequence information corresponding to -40 to -65, bound to both partially pure DBP and extracts from livers of rats as young as 1 week and as old as 25 weeks of age, as assessed by gel mobility shift analysis. This binding was eliminated by coincubation with excess unlabeled -40/-65 double-stranded oligonucleotide and by an oligonucleotide corresponding to the D site of the rat albumin gene. A gel mobility shift-Western immunoblot analysis revealed that the -40/-65 sequence bound to DBP only in liver nuclear extracts from rats older than 3 weeks; maximal binding was observed by 7 weeks of age, and no binding was detected from 1-week-old rat liver extracts. Interestingly, the DBP-binding regions of both CYP2C6 and albumin bind to C/EBP, but this factor is capable of transactivating only the latter gene. Although the DBP-binding regions in these two genes share no obvious sequence similarities, the CYP2C6 region contains consensus palindromic half sites for DBP-related binding proteins and affinity for recombinant DBP of 17-fold greater than that of the D site of albumin. This difference in affinity is probably responsible for the markedly lower amounts of DBP required for half-maximal activation of the CYP2C6 promoter, as compared with the albumin promoter, in transactivation transfection assays. These data indicate that the CYP2C6 gene may be regulated, at least in part, by DBP, a liver transcription factor produced when rats reach puberty that may also be involved in maintenance of albumin gene transcription.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588973      PMCID: PMC364479          DOI: 10.1128/mcb.12.6.2847-2854.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

Review 1.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Expression of the liver-enriched transcriptional activator protein DBP follows a stringent circadian rhythm.

Authors:  J Wuarin; U Schibler
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  The role of cis-acting promoter elements in tissue-specific albumin gene expression.

Authors:  P Maire; J Wuarin; U Schibler
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.

Authors:  P Descombes; M Chojkier; S Lichtsteiner; E Falvey; U Schibler
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

7.  A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.

Authors:  S C Williams; C A Cantwell; P F Johnson
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

8.  A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells.

Authors:  S Cereghini; M Blumenfeld; M Yaniv
Journal:  Genes Dev       Date:  1988-08       Impact factor: 11.361

9.  TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins.

Authors:  D W Drolet; K M Scully; D M Simmons; M Wegner; K T Chu; L W Swanson; M G Rosenfeld
Journal:  Genes Dev       Date:  1991-10       Impact factor: 11.361

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  4 in total

1.  A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor.

Authors:  Y H Lee; M Yano; S Y Liu; E Matsunaga; P F Johnson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

Review 2.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

3.  Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.

Authors:  Chao-Yuan Huang; Shu-Pin Huang; Yu-Mei Hsueh; Lih-Chyang Chen; Te-Ling Lu; Bo-Ying Bao
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

4.  DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.

Authors:  S P Hunger; R Brown; M L Cleary
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.